Advertisement
News
Advertisement

Dicerna makes $29M second close on Series B funding round

Thu, 10/21/2010 - 10:33am
Mass High Tech: The Journal of New England Technology

Dicerna Pharmaceuticals Inc. has added $4 million in a second close of its Series B financing, bringing the round to $29 million. The add-on funding was backed by new investor SR One, the independent corporate healthcare venture capital arm of GlaxoSmithKline.

As part of the financing, SR One partner Brian M. Gallagher Jr. will serve as an observer on Dicerna’s board of directors.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading